"Tallinna Lastehaigla on ainuke kõrgema etapi spetsialiseeritud lastehaigla Eestis, milles on pediaatriliste osakondade kõrval kõik kirurgilised osakonnad (v.a. laste kardiokirurgia) ja laste anestesioloogia-intensiivraviosakond. Traumakabinet võtab vastu E-R 8.30-16.30"

During the past decade, Tallinn Children's Hospital conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tallinn Children's Hospital" #1 sponsor was "Biogen" with 2 trials, followed by "Eisai Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Mats Heyman" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tallinn Children's Hospital" #1 collaborator was "Karolinska Institutet" with 2 trials as a collaborator, "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "ARNAS Civico Di Cristina Benfratelli Hospital" with 1 trials as a collaborator and "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 45 trials.

According to Clinical.Site data, the most researched conditions in "Tallinn Children's Hospital" are "Leukemia, Acute Lymphoblastic" (2 trials), "Muscular Atrophy, Spinal" (2 trials), "Acetaminophen" (1 trials), "Bloodstream Infections (BSI)" (1 trials) and "Complicated Intra-abdominal Infection (cIAI)" (1 trials). Many other conditions were trialed in "Tallinn Children's Hospital" in a lesser frequency.

Most popular intervention types in "Tallinn Children's Hospital" are "Drug" (12 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nusinersen" (2 trials), "Placebo" (2 trials), "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Acetaminophen" (1 trials) and "Blinatumomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tallinn Children's Hospital" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Tallinn Children's Hospital". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in Tallinn Children's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Tallinn Children's Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".